Pages

▼
Friday, September 22, 2023

A Clear Path to Medication Affordability Requires Meeting Patients Where They Are

›
Today’s guest post comes from Kristina Crockett, VP of Product Management at CoverMyMeds. Kristina shares the story of a patient who cut p...
Wednesday, September 20, 2023

NEW: The Drug Channels 2024 Video Webinar Series

›
Drug Channel Institute is pleased to announce The Drug Channels 2024 Video Webinar Series . Join Dr. Adam J. Fein for three live video webin...
Tuesday, September 19, 2023

Do Plan Sponsors Understand How Their PBMs Make Money?

›
Today, the House Committee on Oversight and Accountability will hold a hearing with a subtle and not-at-all pejorative title: The Role of Ph...
Monday, September 18, 2023

Informa Connect’s Patient Support Services Congress

›
Informa Connect’s Patient Support Services Congress November 7-9, 2023 | The Inn at Penn, Philadelphia, PA https://informaconnect.com/pati...
Friday, September 15, 2023

How Payers Are Reacting to Insulin Price Changes

›
Today’s guest post comes from Nicole Mayer, Senior Analyst at MMIT. Nicole summarizes MMIT’s research on payers’ views of two crucial marke...
Wednesday, September 13, 2023

White Bagging Update 2023: Saving Money or Shifting Costs?

›
Time for our annual update on the channels for provider-administered drugs. For 2023, specialty pharmacies—via white, brown, and clear bagg...
Tuesday, September 12, 2023

Available for Preorder: The 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

›
On October 10, 2023, Drug Channels Institute will release 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors ....
Friday, September 08, 2023

What Pharmaceutical Manufacturers Value Most from a Hub

›
Today’s guest post comes from Nasir Ali, Chief Product Officer at CareMetx. Nasir discusses how hubs help patients initiate and adhere to ...
Wednesday, September 06, 2023

What’s Behind CVS Health’s Novel Vertical Integration Strategy for Humira Biosimilars

›
CVS Health has finally revealed its strategy for biosimilars of AbbVie’s Humira. Rather than announce multiple biosimilars for its pharmacy...
Tuesday, August 29, 2023

Drug Channels News Roundup, August 2023: Maximizer Problems, Hospital vs. MD Reimbursement, Bureaucracy vs. Costs, And My Favorite Chart Updated

›
We’re wrapping up one of newsiest summers in recent memory. Time to pack away your bathing suit, send the kids back to school, and cherish t...
Friday, August 25, 2023

Key Predictions in the Accumulator/Maximizer Battle

›
Today’s guest post comes from Chris Dowd, Senior Vice President of Market Development at ConnectiveRx. Chris discusses how such copay adju...
Tuesday, August 22, 2023

A Reality Check on That Blue Shield of California Announcement

›
Last week, Anna Matthews of The Wall Street Journal scored a market-moving scoop with her story about Blue Shield of California’s decision ...